Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- ILa | -.--% | +1,39% | +107,88% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/01/19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01/01/07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23/07/14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/04/06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01/01/06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21/11/10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29/07/13 |
Susan Alpert
LAW | General Counsel | 78 | 01/01/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/07/16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/01/06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/04/15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16/04/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Coordinate società
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+107,88% | 45,97 Mln | |
-3,79% | 184 Mrd | |
-0,84% | 108 Mrd | |
-3,75% | 67,8 Mrd | |
+3,45% | 51,05 Mrd | |
+9,04% | 44,67 Mrd | |
+3,40% | 41,78 Mrd | |
+3,66% | 26,59 Mrd | |
+3,21% | 26,78 Mrd | |
+15,23% | 25,86 Mrd |
- Borsa valori
- Azioni
- Azione EXEN
- Società Exalenz Bioscience Ltd